1.A case of Addison's disease with hyperkalemic neuromyopathy.
Kyoung Tae BAE ; Seung Guel LEE ; Young Sung KIM ; Yi Kyoung SUNG ; Houng Gun PARK ; Yong Gu OH ; Se Gil KI
Journal of Korean Society of Endocrinology 1991;6(1):82-87
No abstract available.
Addison Disease*
2.Clinical application of laparoscopy in gynecology.
Cheol Ho LEE ; Ann Su YI ; Kyoung Do PRK ; Hong Pil KIM ; Il Kyun CHUNG ; Ki Sung CHUNG
Korean Journal of Obstetrics and Gynecology 1993;36(7):1744-1752
No abstract available.
Gynecology*
;
Laparoscopy*
3.Trends in Suicide Methods and Rates among Older Adults in South Korea: A Comparison with Japan.
Subin PARK ; Hochang Benjamin LEE ; Su Yeon LEE ; Go Eun LEE ; Myung Hee AHN ; Ki Kyoung YI ; Jin Pyo HONG
Psychiatry Investigation 2016;13(2):184-189
OBJECTIVE: Lethality of the chosen method during a suicide attempt is a strong risk factor for completion of suicide. We examined whether annual changes in the pattern of suicide methods is related to annual changes in suicide rates among older adults in South Korea and Japan. METHODS: We analyzed annual the World Health Organization data on rates and methods of suicide from 2000 to 2011 in South Korea and Japan. RESULTS: For Korean older adults, there was a significant positive correlation between suicide rate and the rate of hanging or the rate of jumping, and a significant negative correlation between suicide rate and the rate of poisoning. Among older adults in Japan, annual changes in the suicide rate and the pattern of suicide methods were less conspicuous, and no correlation was found between them. CONCLUSION: The results of the present study suggest that the increasing use of lethal suicide methods has contributed to the rise in suicide rates among older adults in South Korea. Targeted efforts to reduce the social acceptability and accessibility of lethal suicide methods might lead to lower suicide rate among older adults in South Korea.
Adult*
;
Humans
;
Japan*
;
Korea*
;
Methods*
;
Poisoning
;
Risk Factors
;
Suicide*
;
World Health Organization
4.Combination therapy with cilostazol, aripiprazole, and donepezil protects neuronal cells from β-amyloid neurotoxicity through synergistically enhanced SIRT1 expression
Hye Jin HEO ; So Youn PARK ; Yi Sle LEE ; Hwa Kyoung SHIN ; Ki Whan HONG ; Chi Dae KIM
The Korean Journal of Physiology and Pharmacology 2020;24(4):299-310
Alzheimer’s disease (AD) is a multi-faceted neurodegenerative disease. Thus, current therapeutic strategies require multitarget-drug combinations to treat or prevent the disease. At the present time, single drugs have proven to be inadequate in terms of addressing the multifactorial pathology of AD, and multitarget-directed drug design has not been successful. Based on these points of views, it is judged that combinatorial drug therapies that target several pathogenic factors may offer more attractive therapeutic options. Thus, we explored that the combination therapy with lower doses of cilostazol and aripiprazole with add-on donepezil (CAD) might have potential in the pathogenesis of AD. In the present study, we found the superior efficacies of donepezil add-on with combinatorial mixture of cilostazol plus aripiprazole in modulation of expression of AD-relevant genes: Aβ accumulation, GSK-3β, P300, acetylated tau, phosphorylated-tau levels, and activation of α-secretase/ADAM 10 through SIRT1 activation in the N2a Swe cells expressing human APP Swedish mutation (N2a Swe cells). We also assessed that CAD synergistically raised acetylcholine release and choline acetyltransferase (CHAT) expression that were declined by increased β-amyloid level in the activated N2a Swe cells. Consequently, CAD treatment synergistically increased neurite elongation and improved cell viability through activations of PI3K, BDNF, β-catenin and a7-nicotinic cholinergic receptors in neuronal cells in the presence of Aβ1-42. This work endorses the possibility for efficient treatment of AD by supporting the synergistic therapeutic potential of donepezil add-on therapy in combination with lower doses of cilostazol and aripiprazole.
5.Combination therapy with cilostazol, aripiprazole, and donepezil protects neuronal cells from β-amyloid neurotoxicity through synergistically enhanced SIRT1 expression
Hye Jin HEO ; So Youn PARK ; Yi Sle LEE ; Hwa Kyoung SHIN ; Ki Whan HONG ; Chi Dae KIM
The Korean Journal of Physiology and Pharmacology 2020;24(4):299-310
Alzheimer’s disease (AD) is a multi-faceted neurodegenerative disease. Thus, current therapeutic strategies require multitarget-drug combinations to treat or prevent the disease. At the present time, single drugs have proven to be inadequate in terms of addressing the multifactorial pathology of AD, and multitarget-directed drug design has not been successful. Based on these points of views, it is judged that combinatorial drug therapies that target several pathogenic factors may offer more attractive therapeutic options. Thus, we explored that the combination therapy with lower doses of cilostazol and aripiprazole with add-on donepezil (CAD) might have potential in the pathogenesis of AD. In the present study, we found the superior efficacies of donepezil add-on with combinatorial mixture of cilostazol plus aripiprazole in modulation of expression of AD-relevant genes: Aβ accumulation, GSK-3β, P300, acetylated tau, phosphorylated-tau levels, and activation of α-secretase/ADAM 10 through SIRT1 activation in the N2a Swe cells expressing human APP Swedish mutation (N2a Swe cells). We also assessed that CAD synergistically raised acetylcholine release and choline acetyltransferase (CHAT) expression that were declined by increased β-amyloid level in the activated N2a Swe cells. Consequently, CAD treatment synergistically increased neurite elongation and improved cell viability through activations of PI3K, BDNF, β-catenin and a7-nicotinic cholinergic receptors in neuronal cells in the presence of Aβ1-42. This work endorses the possibility for efficient treatment of AD by supporting the synergistic therapeutic potential of donepezil add-on therapy in combination with lower doses of cilostazol and aripiprazole.
6.Myoclonic Seizures Occurred during the Brain Tumor Resection in a Patient of the Recurred Malignant Meningioma of Cerebral Frontal Lobe : A case report.
Yun Hong KIM ; Young Jae YI ; Moon Ki KYOUNG ; Hyun Soo KIM ; Sung Ha MUN ; Won Joon CHOI
Korean Journal of Anesthesiology 2007;52(2):241-244
Several suspected etiologies can cause seizures during the resection of a brain tumor via a craniotomy: the tumor itself, intracranial hypertension or the anesthetic agents used, etc. Generalized myoclonic seizures, during general anesthesia in a 44 year old man, who underwent a resection for a relapsed frontal meningioma, were experienced. Anesthesia was induced and maintained using propofol and remifentanil. The myoclonic seizures began 30 minutes after the induction of anesthesia. The administration of rocuronium was unable to stop the involuntary movement. Midazolam was given to cease the seizures, but they continued for a further 105 minutes. After opening the dura mater, the seizures immediately disappeared and did not recur thereafter.
Adult
;
Anesthesia
;
Anesthesia, General
;
Anesthesia, Intravenous
;
Anesthetics
;
Brain Neoplasms*
;
Brain*
;
Craniotomy
;
Dura Mater
;
Dyskinesias
;
Frontal Lobe*
;
Humans
;
Intracranial Hypertension
;
Intraoperative Period
;
Meningioma*
;
Midazolam
;
Propofol
;
Seizures*
7.Development of a contralateral acute subdural hematoma during awake craniotomy for glial tumor in a 12-year-old boy: A case report.
Han Bum JOE ; Sung Yong PARK ; Kwan Sik PARK ; Kyu Dong KYOUNG ; Yi Hwa CHOI ; Kyung Gi CHO ; Bong Ki MOON
Anesthesia and Pain Medicine 2011;6(2):157-159
Contralateral acute subdural hematomas that occur during removal of brain tumors under general anesthesia are extremely rare, and there are no reports of this developing during awake craniotomy for brain tumors. We report a case of a 12-year-old boy who complained of sudden and severe headache and nausea around the completion of removal of a glial tumor of the frontal lobe under awake anesthesia. Postoperative computerized tomography scan revealed the presence of contralateral acute minimal subdural hematoma. We suggest that during craniotomy with awake anesthesia for brain tumors, contralateral acute subdural hematoma may occur, even in the absence of brain bulging or changes in vital signs. Sudden intra-operative headache and nausea should be investigated by immediate postoperative computerized tomography scans to ascertain diagnosis.
Anesthesia
;
Anesthesia, General
;
Brain
;
Brain Neoplasms
;
Child
;
Craniotomy
;
Frontal Lobe
;
Headache
;
Hematoma, Subdural
;
Hematoma, Subdural, Acute
;
Humans
;
Nausea
;
Vital Signs
8.Development of a contralateral acute subdural hematoma during awake craniotomy for glial tumor in a 12-year-old boy: A case report.
Han Bum JOE ; Sung Yong PARK ; Kwan Sik PARK ; Kyu Dong KYOUNG ; Yi Hwa CHOI ; Kyung Gi CHO ; Bong Ki MOON
Anesthesia and Pain Medicine 2011;6(2):157-159
Contralateral acute subdural hematomas that occur during removal of brain tumors under general anesthesia are extremely rare, and there are no reports of this developing during awake craniotomy for brain tumors. We report a case of a 12-year-old boy who complained of sudden and severe headache and nausea around the completion of removal of a glial tumor of the frontal lobe under awake anesthesia. Postoperative computerized tomography scan revealed the presence of contralateral acute minimal subdural hematoma. We suggest that during craniotomy with awake anesthesia for brain tumors, contralateral acute subdural hematoma may occur, even in the absence of brain bulging or changes in vital signs. Sudden intra-operative headache and nausea should be investigated by immediate postoperative computerized tomography scans to ascertain diagnosis.
Anesthesia
;
Anesthesia, General
;
Brain
;
Brain Neoplasms
;
Child
;
Craniotomy
;
Frontal Lobe
;
Headache
;
Hematoma, Subdural
;
Hematoma, Subdural, Acute
;
Humans
;
Nausea
;
Vital Signs
9.Primary Classic Kaposi's Sarcoma of the Penis in an HIV-Negative Patient.
Kwang Ho KIM ; Joon Il CHOI ; Kyoung Ho RYU ; In Ho KANG ; Yi Hsueh LENG ; Jun Woo LEE ; Jong Woo LEE ; Yoon Jung KIM ; Jeong Ki LEE
Korean Journal of Urology 2010;51(11):803-806
Kaposi's sarcoma (KS) is a multifocal hemorrhagic sarcoma that occurs primarily on the extremities. KS limited to the penis is rare and a well-recognized manifestation of acquired immune deficiency syndrome (AIDS). However, KS confined to the penis is extraordinary in human immunodeficiency virus (HIV)-negative patients. We present the case of a 68-year-old man with a dark reddish ulcerated nodule on the penile skin, which was reported as a nodular stage of KS. We detected no evidence of immunosuppression or AIDS or systemic involvements in further evaluations. In his past medical history, the patient had undergone three transurethral resections of bladder tumors due to urothelial cell carcinoma since 2000 and total gastrectomy, splenectomy, and adjuvant fluorouracil/cisplatin chemotherapy for 7 months due to advanced gastric carcinoma in 2005. The patient was circumcised and has had no recurrence for 2 years.
Acquired Immunodeficiency Syndrome
;
Aged
;
Extremities
;
Gastrectomy
;
HIV
;
HIV Seronegativity
;
Humans
;
Immunosuppression
;
Male
;
Penile Neoplasms
;
Penis
;
Recurrence
;
Sarcoma
;
Sarcoma, Kaposi
;
Skin
;
Splenectomy
;
Ulcer
;
Urinary Bladder Neoplasms
10.Changes in diurnal variation of thyrotropin secretion in nonthyroid- al illness and its mechanism.
Bo Youn CHO ; Min Ho SHONG ; Ka Hee YI ; Jae Joon KOH ; Kyung Soo KO ; Kyoung Soo PARK ; Seong Yeon KIM ; Hong Kyu LEE ; Chang Soon KOH ; Hun Ki MIN
Journal of Korean Society of Endocrinology 1991;6(2):133-140
No abstract available.
Thyrotropin*